A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms

Cell Reports

Volumn 15, Issue 10, 2016, Pages 2136-2146

  Choi, In Young ^a   Piccio, Laura ^b   Childress, Patra ^c   Bollman, Bryan ^b   Ghosh, Arko ^a   Brandhorst, Sebastian ^a   Suarez, Jorge ^a   Michalsen, Andreas ^d   Cross, Anne H ^b   Morgan, Todd E ^a   Wei, Min ^a   Paul, Friedemann ^d,e   Bock, Markus ^d,e   Longo, Valter D ^a,c,f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CORTICOSTERONE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HERMES ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL REGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET; DIET THERAPY; DISEASE SEVERITY; FASTING MIMICKING DIET; FEASIBILITY STUDY; FEMALE; IMMUNOREACTIVITY; KETOGENIC DIET; LOW CALORY DIET; MOUSE; MULTIPLE SCLEROSIS; NERVE REGENERATION; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REMYELINIZATION; SYMPTOM; TH1 CELL; TH17 CELL; TREATMENT DURATION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; DIET RESTRICTION; DISEASE MODEL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE COUNT; MYELIN SHEATH; OLIGODENDROGLIA; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REGENERATION; SPINAL CORD; SPLEEN;

ANIMALS; ANTIGENS; APOPTOSIS; AUTOIMMUNITY; DIET; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FASTING; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OLIGODENDROGLIA; PEPTIDE FRAGMENTS; REGENERATION; SPINAL CORD; SPLEEN;

EID: 84969769350     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.05.009     Document Type: Article

References (36)

1. *. Annu. Rev. Immunol. 2000, 18:309-345.
2. Brandhorst S., Choi I.Y., Wei M., Cheng C.W., Sedrakyan S., Navarrete G., Dubeau L., Yap L.P., Park R., Vinciguerra M., et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab. 2015, 22:86-99.
3. Brusaferri F., Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J. Neurol. 2000, 247:435-442.
4. Ce P., Gedizlioglu M., Gelal F., Coban P., Ozbek G. Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis. Eur. J. Neurol. 2006, 13:857-861.
5. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 2002, 346:165-173.
6. Cheng C.W., Adams G.B., Perin L., Wei M., Zhou X., Lam B.S., Da Sacco S., Mirisola M., Quinn D.I., Dorff T.B., et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell 2014, 14:810-823.
7. Dhib-Jalbut S. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis. Neurology 2007, 68:S13-S21. discussion S43-S54.
8. Esposito M., Ruffini F., Bellone M., Gagliani N., Battaglia M., Martino G., Furlan R. Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation. J. Neuroimmunol. 2010, 220:52-63.
9. Esquifino A.I., Cano P., Jimenez-Ortega V., Fernández-Mateos M.P., Cardinali D.P. Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J. Neuroinflammation 2007, 4:6.
10. Fletcher J.M., Lalor S.J., Sweeney C.M., Tubridy N., Mills K.H. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010, 162:1-11.
11. Fontana L., Partridge L., Longo V.D. Extending healthy life span--from yeast to humans. Science 2010, 328:321-326.
12. Friese M.A., Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?. Brain 2005, 128:1747-1763.
13. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
14. Guevara-Aguirre J., Balasubramanian P., Guevara-Aguirre M., Wei M., Madia F., Cheng C.W., Hwang D., Martin-Montalvo A., Saavedra J., Ingles S., et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 2011, 3:70ra13.
15. Hemmer B., Archelos J.J., Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 2002, 3:291-301.
16. Herold M.J., McPherson K.G., Reichardt H.M. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 2006, 63:60-72.
17. Kafami L., Raza M., Razavi A., Mirshafiey A., Movahedian M., Khorramizadeh M.R. Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice. Avicenna J. Med. Biotechnol. 2010, 2:47-52.
18. Kim do Y., Hao J., Liu R., Turner G., Shi F.D., Rho J.M. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS ONE 2012, 7:e35476.
19. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
20. Lee C., Safdie F.M., Raffaghello L., Wei M., Madia F., Parrella E., Hwang D., Cohen P., Bianchi G., Longo V.D. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 2010, 70:1564-1572.
21. Longo V.D., Mattson M.P. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014, 19:181-192.
22. Lucchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999, 122:2279-2295.
23. Nath N., Khan M., Paintlia M.K., Singh I., Hoda M.N., Giri S. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J. Immunol. 2009, 182:8005-8014.
24. Pender M.P., Greer J.M. Immunology of multiple sclerosis. Curr. Allergy Asthma Rep. 2007, 7:285-292.
25. Piccio L., Stark J.L., Cross A.H. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J. Leukoc. Biol. 2008, 84:940-948.
26. Planey S.L., Litwack G. Glucocorticoid-induced apoptosis in lymphocytes. Biochem. Biophys. Res. Commun. 2000, 279:307-312.
27. Raine C.S., Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 1993, 52:199-204.
28. Ransohoff R.M. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 2012, 15:1074-1077.
29. Roth P., Wick W., Weller M. Steroids in neurooncology: actions, indications, side-effects. Curr. Opin. Neurol. 2010, 23:597-602.
30. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
31. Torkildsen O., Brunborg L.A., Myhr K.M., Bø L. The cuprizone model for demyelination. Acta Neurol. Scand. Suppl. 2008, 188:72-76.
32. Uttner I., Müller S., Zinser C., Maier M., Süssmuth S., Claus A., Ostermann B., Elitok E., Ecker D., Brettschneider J., et al. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS. Neurology 2005, 64:1971-1973.
33. Vegiopoulos A., Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol. Cell. Endocrinol. 2007, 275:43-61.
34. Wingerchuk D.M., Carter J.L. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin. Proc. 2014, 89:225-240.
35. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 1998, 18:601-609.
36. Zeng H., Yang K., Cloer C., Neale G., Vogel P., Chi H. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 2013, 499:485-490.